Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$354K Buy
2,609
+3
+0.1% +$408 0.11% 96
2024
Q1
$337K Buy
2,606
+4
+0.2% +$483 0.1% 96
2023
Q4
$298K Buy
2,602
+4
+0.2% +$399 0.1% 99
2023
Q3
$236K Buy
2,598
+5
+0.2% +$516 0.09% 105
2023
Q2
$292K Buy
2,593
+4
+0.2% +$423 0.1% 103
2023
Q1
$271K Buy
2,589
+4
+0.2% +$418 0.1% 104
2022
Q4
$286K Buy
2,585
+3
+0.1% +$314 0.1% 99
2022
Q3
$226K Buy
2,582
+5
+0.2% +$454 0.09% 105
2022
Q2
$201K Buy
2,577
+5
+0.2% +$413 0.07% 113
2022
Q1
$219K Buy
2,572
+4
+0.2% +$383 0.07% 118
2021
Q4
$308K Hold
2,568
0.1% 106
2021
Q3
$331K Hold
2,568
0.11% 98
2021
Q2
$308K Hold
2,568
0.11% 98
2021
Q1
$270K Hold
2,568
0.1% 101
2020
Q4
$261K Hold
2,568
0.1% 111
2020
Q3
$216K Buy
+2,568
New +$200K 0.1% 115
2020
Q1
Sell
-2,568
Closed -$202K 122
2019
Q4
$202K Hold
2,568
0.08% 120
2019
Q3
$204K Hold
2,568
0.08% 117
2019
Q2
$215K Hold
2,568
0.09% 115
2019
Q1
$203K Buy
+2,568
New +$187K 0.09% 117
2018
Q4
Sell
-2,568
Closed -$205K 119
2018
Q3
$205K Buy
+2,568
New +$192K 0.08% 116
2018
Q2
Sell
-3,118
Closed -$240K 121
2018
Q1
$240K Hold
3,118
0.1% 106
2017
Q4
$213K Buy
+3,118
New +$207K 0.09% 116

Other funds holding XYL

Karpas Strategies's XYL Position: Q2 2024 in Review

Karpas Strategies increased its Xylem (XYL) stake by 0.12% in Q2 2024, buying an estimated $408 and bringing the position to 2,609 shares worth $354K. The position accounts for 0.11% of the portfolio, ranked #96.

Karpas Strategies first reported a position in XYL in Q4 2017 and has held it in 23 quarters since. 1,033 funds tracked by Wall St. Rank hold XYL as of Q2 2024.

  • Karpas Strategies held 2,609 shares of Xylem worth $354K as of Q2 2024.
  • Karpas Strategies bought 3 Xylem shares in Q2 2024, an estimated $408.
  • Xylem made up 0.11% of Karpas Strategies's portfolio in Q2 2024, its #96 holding.
  • Karpas Strategies first reported a position in Xylem in Q4 2017 and has held it in 23 quarters since.
  • 1,033 funds tracked by Wall St. Rank held Xylem as of Q2 2024.

Based on Karpas Strategies's 13F filing for Q2 2024, filed 30 Jul 2024.